• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A new neurofeedback strategy to treat pain

Bioengineer by Bioengineer
August 13, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A novel neurofeedback treatment may help to treat chronic pain in the future

IMAGE

Credit: (c) Current Biology

Chronic pain is one of the most important health priorities of the 21st century, with a socioeconomic cost that may far exceed other most other medical problems. It is the leading reason why people stop working prematurely, and a leading cause of loss of independence in the elderly leading to requirements for care. And the magnitude of the problem continues to increase as society ages. The lack of effective drugs for pain has led to an urgency to develop new treatments, with technology-based approaches being an potentially important avenue for innovation.

A new approach to treating a range of neurological and psychiatric treatments is Decoded Neurofeedback (DecNef), in which patients aim to control how information is encoded in their brain using neurofeedback of their brain activity measured using functional neuroimaging. The AMED Nou-Pro project has been exploring applications of DecNef to several conditions, and here we report a preliminary study into the feasibility of using DecNef to control pain.

The study, published in the forthcoming issue of Current Biology, is a preclinical study that aimed to see if pain is potentially controllable by DecNef. We designed a new type of DecNef paradigm, in which volunteers had to try and make the pain ‘clearer’ in their mind, to help a computer read how much pain they were in by studying their brain activity. If the computer could read their pain well, it could work out how to give them less pain later in the experiment.

We found subjects were not easily able to directly control their pain activity in the brain, suggesting that conventional DecNef for pain might be difficult. But instead we found that DecNef had a different effect: it seemed to be boosting the brains’ natural ability to control pain – by enhancing a system caused the ‘endogenous pain control system’. This system is the system that normally tunes how much pain is felt, and allows us to naturally reduce our pain in a wide variety of everyday situations. Importantly, this system seems to be dysfunctional in chronic pain, and so DecNef might provide a way to boost this system to treat pain.

###

Media Contact
Mieko Namba
[email protected]

Tags: Medicine/HealthPain
Share12Tweet8Share2ShareShareShare2

Related Posts

ICU Nurses’ Perspectives on End-of-Life Care

October 5, 2025

Exchange Transfusion Impact on Severe Infant Pertussis

October 5, 2025

Smyd3 Loss Boosts WAT Browning via PPARγ Enhancement

October 5, 2025

Spectator Medicine: Analyzing Men’s Ice Hockey Health Trends

October 5, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ICU Nurses’ Perspectives on End-of-Life Care

Exploring Splicing Patterns in Medicinal Rheum Palmatum

Exchange Transfusion Impact on Severe Infant Pertussis

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.